Home › Calculator › JAGX Dividend Calculator 2026
JAGX Dividend DRIP Calculator 2026
210.50% YieldHealthcareJaguar Health, Inc. · NASDAQ
Price: $0.95 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When JAGX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your JAGX snowball 📈
$10,000 in JAGX → $934624681077020.75M in 10 years · $77,849,274,564,476,470,000.00/month
About Jaguar Health, Inc. (JAGX) — Dividend Analysis 2026
Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health. Presently, the company markets Mytesi, an approved medication providing symptomatic relief for noninfectious diarrhea experienced by adults with HIV/AIDS undergoing antiretroviral therapy. Beyond its commercial product, Jaguar Health is actively advancing Crofelemer, the active pharmaceutical ingredient in Mytesi, for a broad spectrum of additional indications. These include managing diarrhea associated with cancer therapy, seeking orphan drug designation for symptomatic relief in infants and children with congenital diarrheal disorders, and for adult and pediatric patients suffering from short bowel syndrome with intestinal failure. Further potential applications encompass supportive care for diarrhea linked to inflammatory bowel diseases, diarrhea-predominant irritable bowel syndrome (IBS-D), and idiopathic or functional diarrhea. Their pipeline also features lechlemer, a next-generation anti-secretory agent being developed to combat cholera. In the animal health sector, they are developing Canalevia, an oral, plant-derived drug candidate designed to address chemotherapy-induced diarrhea and exercise-induced diarrhea in canines. Established in 2013, Jaguar Health, Inc. maintains its headquarters in San Francisco, California.
Compare JAGX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full JAGX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open JAGX position with:
🌍 JAGX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold JAGX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 210.50% | 207.70% | $21,050 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 178.92% | 176.12% | $17,892 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 168.40% | 165.60% | $16,840 / yr |
| 🇬🇧 UK ISA | 0% | 210.50% | 207.70% | $21,050 / yr |
| 🇬🇧 UK Taxable | 8.75% | 192.08% | 189.28% | $19,208 / yr |
| 🇨🇦 TFSA | 0% | 210.50% | 207.70% | $21,050 / yr |
| 🇨🇦 CA Taxable | 25% | 157.88% | 155.07% | $15,788 / yr |
| 🇦🇺 Super (pension) | 15% | 178.92% | 176.12% | $17,892 / yr |
| 🇦🇺 AU Taxable | 30% | 147.35% | 144.55% | $14,735 / yr |
| 🇩🇪 DE Taxable | 26.375% | 154.98% | 152.18% | $15,498 / yr |
| 🇫🇷 FR Taxable | 30% | 147.35% | 144.55% | $14,735 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 JAGX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 JAGX Dividend Payment Schedule
JAGX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 JAGX vs Healthcare Benchmarks
How JAGX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for JAGX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ JAGX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2025-12-11 | 7,377 | — | — | ||
| A-Award | 2025-12-11 | 7,377 | $1.44 | $10.6K | ||
| A-Award | 2025-12-11 | 11,740 | — | — | ||
| A-Award | 2025-12-11 | 11,740 | $1.44 | $16.9K | ||
| A-Award | 2025-12-11 | 28,592 | — | — | ||
| A-Award | 2025-12-11 | 28,592 | $1.44 | $41.2K | ||
| A-Award | 2025-12-11 | 11,740 | — | — | ||
| A-Award | 2025-12-11 | 11,740 | $1.44 | $16.9K | ||
| A-Award | 2025-12-11 | 11,740 | — | — | ||
| A-Award | 2025-12-11 | 11,740 | $1.44 | $16.9K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the JAGX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Jaguar Health, Inc. (JAGX) is currently trading at $0.95, 100% below its 52-week high. The current dividend yield is 210.50% based on an annual payout of $2.00 per share.
JAGX (Jaguar Health, Inc.) — 210.50% Dividend Yield Analysis
Jaguar Health, Inc. (JAGX) is a healthcare stock currently trading at $0.95 with a dividend yield of 210.50%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (210.50%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.